Psychobiotic Effects on Anxiety Are Modulated by Lifestyle Behaviors: A Randomized Placebo-Controlled Trial on Healthy Adults
- PMID: 37049546
- PMCID: PMC10096963
- DOI: 10.3390/nu15071706
Psychobiotic Effects on Anxiety Are Modulated by Lifestyle Behaviors: A Randomized Placebo-Controlled Trial on Healthy Adults
Abstract
Psychobiotics are modulators of the Microbiota-Gut-Brain Axis (MGBA) with promising benefits to mental health. Lifestyle behaviors are established modulators of both mental health and the MGBA. This randomized placebo-controlled clinical trial (NCT04823533) on healthy adults (N = 135) tested 4 weeks of probiotic supplementation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175). We assessed effects on wellbeing, quality of life, emotional regulation, anxiety, mindfulness and interoceptive awareness. We then analyzed if lifestyle behaviors modulated probiotic effectiveness. Results showed no significant effects of probiotic intake in whole sample outcomes. Correlational analyses revealed Healthy Behaviors were significantly correlated with wellbeing across scales. Moreover, the linear mixed-effects model showed that the interaction between high scores in Healthy Behaviors and probiotic intake was the single significant predictor of positive effects on anxiety, emotional regulation, and mindfulness in post-treatment outcomes. These findings highlight the relevance of controlling for lifestyle behaviors in psychobiotic and mental health research.
Keywords: Mediterranean diet; embodied mind; lifestyle behaviors; mental health; microbiota-gut-brain axis; psychobiotics; well-being.
Conflict of interest statement
The products (probiotic and placebo) used in this clinical trial were provided by Rosell-Lallemand SAS, France. None of the authors has any financial, commercial, or economical relationship with the funding sponsor.
Figures
References
-
- Misera A., Liśkiewicz P., Łoniewski I., Skonieczna-Żydecka K., Samochowiec J. Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression. Pharmaceuticals. 2021;14:952. doi: 10.3390/ph14100952. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 3190491/Agencia Nacional de Investigación y Desarrollo
- 11180620/Agencia Nacional de Investigación y Desarrollo
- 1190610/Agencia Nacional de Investigación y Desarrollo
- 1181355/Fondo Nacional de Desarrollo Cientifico y Tenológico
- ICS13_005/Millennium Science Initiative Program/Millennium Institute for Research on Depression and Personality-MIDAP
LinkOut - more resources
Full Text Sources
